Detailed information for compound 989601

Basic information

Technical information
  • TDR Targets ID: 989601
  • Name: 1-(1,3-dihydroinden-2-ylideneamino)-3-(4-meth oxyphenyl)thiourea
  • MW: 311.401 | Formula: C17H17N3OS
  • H donors: 2 H acceptors: 0 LogP: 3.05 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)NC(=S)NN=C1Cc2c(C1)cccc2
  • InChi: 1S/C17H17N3OS/c1-21-16-8-6-14(7-9-16)18-17(22)20-19-15-10-12-4-2-3-5-13(12)11-15/h2-9H,10-11H2,1H3,(H2,18,20,22)
  • InChiKey: UOCOSGYGYWYBHS-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 1-(indan-2-ylideneamino)-3-(4-methoxyphenyl)thiourea
  • 1-(2-indanylideneamino)-3-(4-methoxyphenyl)thiourea
  • ZINC07014398

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Treponema pallidum NADH oxidase 0.0017 0.0024 0.5
Plasmodium vivax dihydrolipoyl dehydrogenase, apicoplast, putative 0.0017 0.0024 0.1013
Echinococcus granulosus flap endonuclease 1 0.0027 0.0091 0.0121
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0126 0.0744 1
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0126 0.0744 1
Mycobacterium tuberculosis Probable dehydrogenase 0.0113 0.066 0.8837
Brugia malayi Flap endonuclease-1 0.0027 0.0091 0.0121
Trypanosoma cruzi trypanothione reductase, putative 0.0017 0.0024 0.0033
Plasmodium falciparum thioredoxin reductase 0.005 0.0239 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0113 0.066 0.8837
Mycobacterium tuberculosis Probable oxidoreductase 0.0126 0.0744 1
Plasmodium vivax thioredoxin reductase, putative 0.005 0.0239 1
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0017 0.0024 0.0024
Leishmania major flap endonuclease-1 (FEN-1), putative 0.0027 0.0091 0.0123
Plasmodium vivax dihydrolipoyl dehydrogenase, mitochondrial, putative 0.0017 0.0024 0.1013
Echinococcus granulosus thioredoxin glutathione reductase 0.005 0.0239 0.0317
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0113 0.066 0.8837
Toxoplasma gondii pyruvate dehydrogenase complex subunit PDH-E3II 0.0017 0.0024 0.1013
Giardia lamblia NADH oxidase lateral transfer candidate 0.0017 0.0024 0.2652
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Loa Loa (eye worm) hypothetical protein 0.1134 0.7413 0.9811
Brugia malayi Thioredoxin reductase 0.005 0.0239 0.0317
Leishmania major trypanothione reductase 0.005 0.0239 0.0323
Trichomonas vaginalis glutathione reductase, putative 0.0017 0.0024 0.0651
Leishmania major 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein 0.0017 0.0024 0.0033
Trypanosoma brucei flap endonuclease-1 (FEN-1), putative 0.0027 0.0091 0.0123
Trypanosoma brucei C-8 sterol isomerase, putative 0.1134 0.7413 1
Plasmodium falciparum flap endonuclease 1 0.0027 0.0091 0.3822
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Leishmania major acetoin dehydrogenase e3 component-like protein 0.0017 0.0024 0.0033
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0017 0.0024 1
Echinococcus multilocularis sentrin specific protease 8 0.007 0.0372 0.0372
Plasmodium falciparum glutathione reductase 0.005 0.0239 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.005 0.0239 0.0239
Loa Loa (eye worm) flap endonuclease-1 0.0027 0.0091 0.0121
Trichomonas vaginalis mercuric reductase, putative 0.0017 0.0024 0.0651
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Entamoeba histolytica Flap nuclease, putative 0.0027 0.0091 0.2456
Trichomonas vaginalis Clan CE, family C48, Ulp1-like cysteine peptidase 0.007 0.0372 1
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0017 0.0024 0.0032
Toxoplasma gondii flap structure-specific endonuclease 1, putative 0.0027 0.0091 0.3822
Leishmania major C-8 sterol isomerase-like protein 0.1134 0.7413 1
Trichomonas vaginalis Sentrin-specific protease, putative 0.007 0.0372 1
Trichomonas vaginalis Clan CE, family C48, Ulp1-like cysteine peptidase 0.007 0.0372 1
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0.0024 0.5
Trypanosoma cruzi C-8 sterol isomerase, putative 0.1134 0.7413 1
Loa Loa (eye worm) glutathione reductase 0.005 0.0239 0.0317
Toxoplasma gondii NADPH-glutathione reductase 0.0017 0.0024 0.1013
Entamoeba histolytica Ulp1 protease family, C-terminal catalytic domain containing protein 0.007 0.0372 1
Loa Loa (eye worm) thioredoxin reductase 0.005 0.0239 0.0317
Trichomonas vaginalis flap endonuclease-1, putative 0.0027 0.0091 0.2456
Brugia malayi vesicular acetylcholine transporter unc-17 0.1155 0.7555 1
Brugia malayi Ulp1 protease family, C-terminal catalytic domain containing protein 0.007 0.0372 0.0493
Plasmodium falciparum dihydrolipoyl dehydrogenase, mitochondrial 0.0017 0.0024 0.1013
Brugia malayi ERG2 and Sigma1 receptor like protein 0.1134 0.7413 0.9811
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.005 0.0239 0.2985
Schistosoma mansoni hypothetical protein 0.0163 0.0986 0.1305
Schistosoma mansoni vesicular acetylcholine transporter 0.1155 0.7555 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0017 0.0024 0.5
Giardia lamblia Flap structure-specific endonuclease 0.0027 0.0091 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0017 0.0024 0.5
Schistosoma mansoni family C48 unassigned peptidase (C48 family) 0.007 0.0372 0.0493
Plasmodium falciparum thioredoxin reductase 0.0017 0.0024 0.1013
Onchocerca volvulus Vesicular acetylcholine transporter homolog 0.1155 0.7555 1
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0017 0.0024 0.0033
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0126 0.0744 1
Loa Loa (eye worm) vesicular acetylcholine transporter unc-17 0.1155 0.7555 1
Trypanosoma brucei dihydrolipoyl dehydrogenase 0.0017 0.0024 0.0033
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0017 0.0024 0.0033
Loa Loa (eye worm) Ulp1 protease 0.007 0.0372 0.0493
Trypanosoma brucei dihydrolipoamide dehydrogenase, point mutation 0.0017 0.0024 0.0033
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0017 0.0024 0.5
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast 0.0017 0.0024 0.1013
Trypanosoma cruzi hypothetical protein 0.007 0.0372 0.0502
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0017 0.0024 0.0032
Trypanosoma cruzi flap endonuclease-1 (FEN-1), putative 0.0027 0.0091 0.0123
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0017 0.0024 0.0033
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0017 0.0024 0.0033
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0017 0.0024 0.5
Echinococcus multilocularis flap endonuclease 1 0.0027 0.0091 0.0091
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0113 0.066 0.8837
Trypanosoma cruzi trypanothione reductase, putative 0.005 0.0239 0.0323
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0017 0.0024 0.0032
Echinococcus multilocularis geminin 0.0163 0.0986 0.0986
Brugia malayi glutathione reductase 0.005 0.0239 0.0317
Schistosoma mansoni hypothetical protein 0.0163 0.0986 0.1305
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0113 0.066 0.8837
Plasmodium vivax flap endonuclease 1, putative 0.0027 0.0091 0.3822
Toxoplasma gondii thioredoxin reductase 0.005 0.0239 1
Trichomonas vaginalis Clan CE, family C48, Ulp1-like cysteine peptidase 0.007 0.0372 1
Mycobacterium tuberculosis Probable reductase 0.0113 0.066 0.8837
Loa Loa (eye worm) hypothetical protein 0.058 0.3745 0.4957
Trypanosoma brucei trypanothione reductase 0.005 0.0239 0.0323
Plasmodium vivax glutathione reductase, putative 0.005 0.0239 1
Echinococcus granulosus geminin 0.0163 0.0986 0.1305
Echinococcus granulosus sentrin specific protease 8 0.007 0.0372 0.0493
Plasmodium falciparum glutathione reductase 0.0017 0.0024 0.1013
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0017 0.0024 0.0033
Schistosoma mansoni flap endonuclease-1 0.0025 0.0074 0.0098
Echinococcus multilocularis vesicular acetylcholine transporter 0.1155 0.7555 0.7555
Echinococcus granulosus vesicular acetylcholine transporter 0.1155 0.7555 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.